Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Apr 17, 2026

Aehr Test Systems (AEHR): +123% Surge in 30 Days on AI Chip Testing Momentum

Key Takeaways

  • AEHR stock surged +123% over the past 30 days, driven by record production orders from hyperscale AI customers for testing custom AI processor ASICs.
  • The stock climbed +181% over the past quarter, fueled by strong demand in AI data center infrastructure and semiconductor testing equipment.
  • Recent Q3 fiscal earnings showed revenue of $10.3 million but beat EPS expectations at -$0.05, with bookings exceeding $37 million tied to AI growth.
  • Momentum from the broader semiconductor rally, including peers like NVDA and AVGO, amplified AEHR's price movement.
  • Key factors include company-specific wins in AI chip burn-in testing and positive analyst sentiment on momentum.

Aehr Test Systems (AEHR): Company Overview and Market Position

Aehr Test Systems, Inc. designs, manufactures, and sells systems for testing, burning-in, and monitoring semiconductor devices at the wafer level, singulated die, or packaged part form. The company's core business centers on advanced burn-in testing equipment, particularly for high-power semiconductors like silicon carbide (SiC) power devices used in electric vehicles (EVs) and power management, as well as emerging applications in AI processors and data centers. In the competitive semiconductor equipment industry, Aehr maintains niche leadership in wafer-level test and burn-in solutions, setting itself apart with its FOX-XP and FOX-CP systems tailored for next-generation chips. From what I see, this positioning in high-growth areas like AI infrastructure and EVs has contributed significantly to the recent stock price strength, as demand surges for reliable testing of complex, high-reliability chips.

AEHR Stock Performance: 30-Day vs. Quarterly Gains

Over the last 30 days, AEHR stock rose from a closing price of approximately $36.31 to $80.85, marking a +123% gain. The movement proved highly volatile and trend-driven, featuring sharp spikes after key announcements, including multi-day surges exceeding 50% in a single week.

In the past quarter, the stock advanced from around $28.81 to $80.85, delivering a +181% increase. This performance showed a steady uptrend with bouts of volatility and accelerated gains in the final month tied to AI catalysts. It clearly outpaced broader market trends, highlighting sector-specific momentum.

Key Drivers Behind AEHR's 30-Day Rally

The main catalyst came from a record $41 million production order from a leading hyperscale AI customer for package-level burn-in testing of custom AI processor application-specific integrated circuits (ASICs), which sparked a 15%+ single-day surge. This built on second-half bookings surpassing $92 million, pointing to robust demand. Q3 fiscal earnings reported on April 7 showed revenue of $10.3 million, missing expectations, but EPS beat at -$0.05 alongside $37 million in bookings from AI and data center demand, which lifted sentiment. I also reviewed analyst notes emphasizing momentum, including golden cross technical patterns and outperformance against computer peers. Sector tailwinds from AI chip testing enthusiasm added further lift. One thing that stands out is how I cross-checked these trends using Tickeron’s AI Trend Prediction Engine, which aligned with the bullish signals.

Quarterly Performance Drivers for AEHR

The quarter's +181% rally was driven by sustained AI and data center semiconductor demand, with Aehr securing multiple FOX XP system deals connected to infrastructure growth. Fiscal Q2 results in early January reinstated guidance amid better AI processor visibility, despite softer revenue, establishing a bullish outlook. Broader developments, like the semiconductor rally sparked by NVDA and AVGO, heightened exposure. Institutional interest rose alongside high trading volumes, while favorable macro conditions for tech spending and lower rates bolstered high-beta (2.29) stocks like AEHR. In my view, cumulative AI orders had the most substantial impact here.

Trending AI Robots: A Tool I Use for Volatile Markets

One resource I've found valuable for navigating stocks like AEHR is Tickeron’s Trending AI Robots page, which highlights top-performing AI trading bots from its library of hundreds of algorithms trading thousands of tickers across markets. These bots are selected based on recent metrics like win rate, profit factor, and Sharpe ratio, covering strategies from short-term scalping to long-term trend following. Each includes details on timeframe, risk level, historical performance, and assets, making it straightforward to find ones that fit volatile, AI-driven plays. I check this page regularly to see how automated strategies are handling similar trends.

What to Watch Next for AEHR Stock

Looking ahead, I'm watching fiscal Q4 earnings around July 2026 for insights into AI order fulfillment and backlog conversion. Ongoing hyperscale customer wins and silicon photonics progress could keep the momentum going. Broader trends in AI data centers and EV power semis will remain critical, as will macro factors like interest rates affecting tech capex. On the risk side, supply chain disruptions or revenue shortfalls bear monitoring, while new partnerships could spark further upside. This is important because it shapes the path forward in this fast-moving sector.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: AEHR

AEHR sees MACD Histogram just turned negative

AEHR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 21, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 37 instances where the indicator turned negative. In of the 37 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for AEHR moved out of overbought territory on August 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AEHR broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

AEHR moved above its 50-day moving average on August 03, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AEHR crossed bullishly above the 50-day moving average on August 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 251 cases where AEHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 65, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.129) is normal, around the industry mean (8.019). P/E Ratio (19.449) is within average values for comparable stocks, (159.406). AEHR's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.475). AEHR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.006). P/S Ratio (62.500) is also within normal values, averaging (33.263).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Lam Research Corp (NASDAQ:LRCX), Applied Materials (NASDAQ:AMAT), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 63.51B. The market cap for tickers in the group ranges from 555.66K to 676.06B. ASML holds the highest valuation in this group at 676.06B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was -10%. For the same Industry, the average monthly price growth was 70%, and the average quarterly price growth was 74%. ACMR experienced the highest price growth at -1%, while SMTK experienced the biggest fall at -98%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was -12%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was -59%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 34
Price Growth Rating: 48
SMR Rating: 73
Profit Risk Rating: 64
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
AEHR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of burn-in and test equipment for semiconductor manufacturing

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
400 Kato Terrace
Phone
+1 510 623-9400
Employees
136
Web
https://www.aehr.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.